Monthly Archives June 2016

Mallinckrodt Donates One Million Deterra Drug Deactivation Pouches To Support Fight Against Prescription Drug Abuse

MINNEAPOLIS (June 17, 2016) — Mallinckrodt Pharmaceuticals (NYSE: MNK), a global specialty biopharmaceutical company, announced this week that it will purchase and donate more than 1 million Deterra® drug deactivation pouches to help prevent the abuse of prescription pain medications. The Omnidegradable® pouches, made by Minneapolis-based Verde Technologies, use patented Molecular Adsorption Technology (MAT12®) to neutralize the active ingredients in opioid painkillers and other drugs in pill, liquid and transdermal patch forms. A proprietary activated carbon bonds to pharmaceutical compounds when water is added, rendering the drugs ineffective and safe for disposal in any setting – home, clinic or hospital.
Read More